Production (Stage)
Xtant Medical Holdings, Inc.
XTNT
$0.7368
$0.01031.42%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.32% | 26.45% | -154.41% | -76.30% | -111.74% |
| Total Depreciation and Amortization | 6.87% | 12.88% | 21.52% | 24.28% | 113.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.79% | 16.10% | 113.73% | 81.69% | 47.17% |
| Change in Net Operating Assets | 58.19% | 10.85% | 134.70% | -90.07% | -141.72% |
| Cash from Operations | 122.21% | 172.68% | 55.19% | -101.82% | -156.35% |
| Capital Expenditure | -54.08% | -85.12% | -843.50% | -36.23% | -69.52% |
| Sale of Property, Plant, and Equipment | -51.52% | 0.00% | 533.33% | 320.00% | 182.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -69.58% | 75.49% | 56.85% | -21.83% | 96.13% |
| Total Debt Issued | -17.37% | 14.58% | 40.88% | 72.66% | 41.64% |
| Total Debt Repaid | -4.92% | -18.82% | -31.24% | -55.00% | -46.94% |
| Issuance of Common Stock | -- | -- | -68.10% | -- | -- |
| Repurchase of Common Stock | 47.06% | 52.11% | 21.85% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.20% | -172.38% | 508.91% | -193.44% | -990.00% |
| Cash from Financing | -117.74% | -362.77% | -58.63% | 229.44% | 13.35% |
| Foreign Exchange rate Adjustments | 95.92% | -241.56% | 139.62% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.49% | 69.39% | -62.61% | 188.77% | 91.40% |